Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
Colorcon
Accenture
US Army
McKinsey
Cantor Fitzgerald
Citi

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METOCLOPRAMIDE

« Back to Dashboard

Clinical Trials for Metoclopramide

Trial ID Title Status Sponsor Phase Summary
NCT00003213 Drugs to Reduce the Side Effects of Chemotherapy Completed Swiss Group for Clinical Cancer Research Phase 3 RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron is more effective than receiving dexamethasone with metoclopramide for reducing the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either granisetron or metoclopramide in patients treated with chemotherapy.
NCT00008736 Electrogastrography (EGC) in Premature Infants With Feeding Intolerance Completed Children's Hospital of Philadelphia Phase 2 Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
NCT00008736 Electrogastrography (EGC) in Premature Infants With Feeding Intolerance Completed National Center for Research Resources (NCRR) Phase 2 Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Metoclopramide

Condition Name

Condition Name for Metoclopramide
Intervention Trials
Nausea 15
Postoperative Nausea and Vomiting 12
Migraine 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Metoclopramide
Intervention Trials
Vomiting 36
Nausea 35
Migraine Disorders 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Metoclopramide

Trials by Country

Trials by Country for Metoclopramide
Location Trials
United States 200
Canada 17
Egypt 12
Australia 11
Brazil 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Metoclopramide
Location Trials
New York 23
Pennsylvania 14
Texas 13
Illinois 10
Ohio 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Metoclopramide

Clinical Trial Phase

Clinical Trial Phase for Metoclopramide
Clinical Trial Phase Trials
Phase 4 55
Phase 3 29
Phase 2/Phase 3 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Metoclopramide
Clinical Trial Phase Trials
Completed 79
Recruiting 33
Not yet recruiting 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Metoclopramide

Sponsor Name

Sponsor Name for Metoclopramide
Sponsor Trials
Montefiore Medical Center 11
Assiut University 7
Northwestern University 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Metoclopramide
Sponsor Trials
Other 203
Industry 29
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Queensland Health
Dow
Boehringer Ingelheim
Fuji
Fish and Richardson
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.